UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

International journal of molecular sciences, 2022-01, Vol.23 (2), p.929

2022

Volltextzugriff (PDF)

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

Acta diabetologica, 2022-09, Vol.59 (9), p.1255-1256

2022

Volltextzugriff (PDF)

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells

PloS one, 2017-08, Vol.12 (8), p.e0181190

2017

Volltextzugriff (PDF)

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1007-1013

2024

Volltextzugriff (PDF)

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1015-1015

2024

Volltextzugriff (PDF)

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

American journal of human genetics, 2015-07, Vol.97 (1), p.177-185

2015

Volltextzugriff (PDF)

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis

PloS one, 2015-03, Vol.10 (3), p.e0120419-e0120419

2015

Volltextzugriff (PDF)

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-01, Vol.60 (1), p.131-135

2023

Volltextzugriff (PDF)

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-03, Vol.60 (3), p.459-459

2023

Volltextzugriff (PDF)

Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients

Acta diabetologica, 2022-08, Vol.59 (8), p.1113-1116

2022

Volltextzugriff (PDF)

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Genes, 2022-01, Vol.13 (1), p.117

2022

Volltextzugriff (PDF)

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

PloS one, 2013-06, Vol.8 (6), p.e64729-e64729

2013

Volltextzugriff (PDF)

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

Acta diabetologica, 2021-10, Vol.58 (10), p.1425-1428

2021

Volltextzugriff (PDF)

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

PloS one, 2013-07, Vol.8 (7), p.e70159-e70159

2013

Volltextzugriff (PDF)

The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy

Acta diabetologica, 2020-05, Vol.57 (5), p.589-596

2020

Volltextzugriff (PDF)

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

Acta diabetologica, 2022-05, Vol.59 (5), p.747-750

2022

Volltextzugriff (PDF)

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data

Scientific reports, 2017-03, Vol.7 (1), p.61-61, Article 61

2017

Volltextzugriff (PDF)

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus

PloS one, 2015-08, Vol.10 (8), p.e0135855-e0135855

2015

Volltextzugriff (PDF)

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes

PloS one, 2015-10, Vol.10 (10), p.e0140631-e0140631

2015

Volltextzugriff (PDF)

Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing

Acta diabetologica, 2019-05, Vol.56 (5), p.515-523

2019

Volltextzugriff (PDF)

Serum resistin and glomerular filtration rate in patients with type 2 diabetes

PloS one, 2015-03, Vol.10 (3), p.e0119529-e0119529

2015

Volltextzugriff (PDF)

Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitus

PloS one, 2015-04, Vol.10 (4), p.e0124536

2015

Volltextzugriff (PDF)

Interaction Between PPARγ2 Variants and Gender on the Modulation of Body Weight

Obesity (Silver Spring, Md.), 2008-06, Vol.16 (6), p.1467-1470

2008

Volltextzugriff (PDF)

Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals

PloS one, 2012-06, Vol.7 (6), p.e38414-e38414

2012

Volltextzugriff (PDF)

ENPP1 affects insulin action and secretion: evidences from in vitro studies

PloS one, 2011-05, Vol.6 (5), p.e19462

2011

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(98)

Sprache

Englisch
(98)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(78)
Humans
(72)
Female
(50)
Male
(48)
Middle Aged
(39)
Endocrinology & Metabolism
(31)
Diabetes
(30)
Adult
(25)
Insulin Resistance
(25)
Medicine
(25)
Aged
(24)
Cardiovascular System & Cardiology
(21)
Diabetes Mellitus
(20)
Medicine & Public Health
(20)
Cardiac & Cardiovascular Systems
(18)
Risk Factors
(18)
Biological And Medical Sciences
(17)
Internal Medicine
(17)
Diabetes Mellitus, Type 2 - Genetics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes

Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing

Serum resistin and glomerular filtration rate in patients with type 2 diabetes

Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitus

Interaction Between PPARγ2 Variants and Gender on the Modulation of Body Weight

Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals

ENPP1 affects insulin action and secretion: evidences from in vitro studies

Aktive Filter

Suchergebnisse filtern